Epileptologists are highly specialized neurologists who focus exclusively on epilepsy and seizure disorders. They diagnose complex seizure types, investigate causes, and implement personalized treatment plans using cutting-edge diagnostic tools. Epileptologists interpret prolonged EEG data, MRI scans, and video telemetry to pinpoint seizure foci and rule out mimicking conditions. They are especially skilled in managing drug-resistant epilepsy, adjusting antiepileptic therapies based on side effect profiles and seizure frequency. Many patients benefit from surgical evaluation, and epileptologists guide these pathways through intracranial monitoring or neurostimulation options like vagus nerve stimulation or responsive neurostimulation. Pediatric epileptologists also address epilepsy syndromes with developmental impacts, coordinating care with geneticists, educators, and neuropsychologists. Their work reduces seizure burden, improves cognitive outcomes, and supports psychosocial well-being. Epileptologists are often key contributors to clinical trials that test novel therapeutics, from cannabinoid treatments to gene-based approaches. Their collaboration with behavioral specialists enhances care for epilepsy with psychiatric comorbidities. In global health, epileptologists work to reduce stigma and improve access to care in resource-limited settings. With epilepsy affecting over 50 million people worldwide, these specialists remain central to transforming lives through precision-focused, long-term care.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom